Categories
All News

Hemostasis Tests Market Report- Global Industry Analysis | ThromboTherapeutics Inc, Transfusion & Transplantation Technologies

ReportsnReports added Hemostasis Tests Market Research Report created by Report Consultant, which offers detailed insights, revenue details, and other information regarding the global market, and the various trends, drivers, restraints, opportunities, and market till 2028. Hemostasis Tests Market Report offers detailed information regarding the leading key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions and mergers, and market footprint. Hemostasis Tests Market also provides a comparative analysis of the market dynamics pre and post Covid19 outbreak.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3926469

Top Company Profile Analysis in this Report

Alere Inc

Analyticon Biotechnologies AG

Atantares Corp

Atomo Diagnostics Ltd

BioMedica USA LLC (Inactive)

Braun Biosystems, Inc. (Inactive)

Carclo Diagnostic Solutions Ltd

Diagnostica Stago Inc

Edan Instruments Inc

EKF Diagnostics Holdings Plc

Emosis SAS

Fraunhofer Institute for Cell Therapy and Immunology

Grifols SA

Hansjorg Wyss Institute for Biologically Inspired Engineering

Helena Laboratories Corp

HemoSonics LLC

Instrumentation Laboratory Co

Levisonics Inc

Massachusetts General Hospital

Novametics Inc (Inactive)

Ortho-Clinical Diagnostics Inc

Pakwa Technologies

PortaScience Inc

Radiometer Medical ApS

Rappaport Family Institute for Research in the Medical Science

rHealth

Roche Diagnostics International Ltd

Sekisui Diagnostics LLC

Siemens Healthcare Diagnostics GmbH

Siemens Healthcare Diagnostics Inc

Siemens Healthineers AG

SonoMedix, Inc.

SQI Diagnostics Inc

Stichting Lygature

Sysmex Corp

Tarabios

The Binding Site Group Ltd

ThromboTherapeutics Inc

Transfusion & Transplantation Technologies (Inactive)

Universal Biosensors Inc

University of Colorado

University of Michigan

University of Texas Health Science Center at Houston

University of Vermont

Hemostasis Tests Market Report provides comprehensive information about the Hemostasis Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hemostasis screening tests help identify patients with hemostatic defects. It includes the sub-segments Prothrombin time tests, Prothrombin time (PT) POC test, Prothrombin time laboratory tests, Activated partial thromboplastin time (aPTT or PTT) tests, Activated partial thromboplastin time (aPTT) POC tests, Activated partial thromboplastin time (aPTT or PTT) laboratory tests, D-dimer tests, D-dimer POC test and D-dimer laboratory tests.

Scope of this Report-
– Extensive coverage of the Hemostasis Tests under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Hemostasis Tests and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to Buy this Report-
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Hemostasis Tests under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Single User License: US $ 4000
Get FLAT 25% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=3926469

Table of Contents
1.2 List of Figures
2.1 Hemostasis Tests Overview
3 Products under Development
3.1 Hemostasis Tests – Pipeline Products by Stage of Development
3.2 Hemostasis Tests – Pipeline Products by Segment
3.3 Hemostasis Tests – Pipeline Products by Territory
3.4 Hemostasis Tests – Pipeline Products by Regulatory Path
3.5 Hemostasis Tests – Pipeline Products by Estimated Approval Date
4 Hemostasis Tests – Pipeline Products under Development by Companies
4.1 Hemostasis Tests Companies – Pipeline Products by Stage of Development
4.2 Hemostasis Tests – Pipeline Products by Stage of Development
5 Hemostasis Tests Companies and Product Overview
5.1 Alere Inc Company Overview
5.1.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Analyticon Biotechnologies AG Company Overview
5.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
5.3 Atantares Corp Company Overview
5.3.1 Atantares Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 Atomo Diagnostics Ltd Company Overview
5.4.1 Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 BioMedica USA LLC (Inactive) Company Overview
5.5.1 BioMedica USA LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.6 Braun Biosystems, Inc. (Inactive) Company Overview
5.6.1 Braun Biosystems, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.7 Carclo Diagnostic Solutions Ltd Company Overview
5.7.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Diagnostica Stago Inc Company Overview
5.8.1 Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Edan Instruments Inc Company Overview
5.9.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 EKF Diagnostics Holdings Plc Company Overview
5.10.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Emosis SAS Company Overview
5.11.1 Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
5.12 Fraunhofer Institute for Cell Therapy and Immunology Company Overview
5.12.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview
5.13 Grifols SA Company Overview
5.13.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
5.14 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview
5.14.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview
5.15 Helena Laboratories Corp Company Overview
5.15.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
5.16 HemoSonics LLC Company Overview
5.16.1 HemoSonics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 Instrumentation Laboratory Co Company Overview
5.17.1 Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
5.18 Levisonics Inc Company Overview
5.18.1 Levisonics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Massachusetts General Hospital Company Overview
5.19.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.20 Novametics Inc (Inactive) Company Overview
5.20.1 Novametics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.21 Ortho-Clinical Diagnostics Inc Company Overview
5.21.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Pakwa Technologies Company Overview
5.22.1 Pakwa Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.23 PortaScience Inc Company Overview
5.23.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Radiometer Medical ApS Company Overview
5.24.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview
5.25 Rappaport Family Institute for Research in the Medical Science Company Overview
5.25.1 Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview
5.26 rHealth Company Overview
5.26.1 rHealth Pipeline Products & Ongoing Clinical Trials Overview
5.27 Roche Diagnostics International Ltd Company Overview
5.27.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.28 Sekisui Diagnostics LLC Company Overview
5.28.1 Sekisui Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.29 Siemens Healthcare Diagnostics GmbH Company Overview
5.29.1 Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.30 Siemens Healthcare Diagnostics Inc Company Overview
5.30.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 Siemens Healthineers AG Company Overview
5.31.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
5.32 SonoMedix, Inc. Company Overview
5.32.1 SonoMedix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.33 SQI Diagnostics Inc Company Overview
5.33.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Stichting Lygature Company Overview
5.34.1 Stichting Lygature Pipeline Products & Ongoing Clinical Trials Overview
5.35 Sysmex Corp Company Overview
5.35.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
5.36 Tarabios Company Overview
5.36.1 Tarabios Pipeline Products & Ongoing Clinical Trials Overview
5.37 The Binding Site Group Ltd Company Overview
5.37.1 The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.38 ThromboTherapeutics Inc Company Overview
5.38.1 ThromboTherapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.39 Transfusion & Transplantation Technologies (Inactive) Company Overview
5.39.1 Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.40 Universal Biosensors Inc Company Overview
5.40.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of Colorado Company Overview
5.41.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.42 University of Michigan Company Overview
5.42.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.43 University of Texas Health Science Center at Houston Company Overview
5.43.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
5.44 University of Vermont Company Overview
5.44.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview
6 Hemostasis Tests- Recent Developments
6.1 Nov 12, 2020: Earnings release Q4 FY 2020 : Siemens
6.2 Aug 06, 2020: Earnings release and financial results Q3 FY 2020: Strong team performance in challenging times
6.3 Aug 06, 2020: Siemens profit falls on COVID-19 issues, taxes
6.4 Jul 23, 2020: Abcam: provides full year trading update 2020
6.5 Jul 13, 2020: Judith Wiese appointed managing board member and labor director of Siemens AG
6.6 Jul 13, 2020: Thermo Fisher Scientific and first genetics JCS partner to develop next-generation sequencing-based diagnostics in Russia
6.7 Jul 08, 2020: Michael Peter to be Siemens Mobility’s sole CEO
6.8 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.9 Apr 14, 2020: Siemens Managing Board sets up COVID-19 aid fund
6.10 Mar 02, 2020: Russia’s sanctions-hit Power Machines to sell its stake in JV with Siemens
6.11 Feb 27, 2020: Grifols reaches revenue of EUR 5,100 million, a 13.6% increase, and raises its profits to EUR 625 million
6.12 Feb 27, 2020: SQI Diagnostics reports first quarter 2020 results
6.13 Feb 26, 2020: BioPorto announces preliminary financial result for 2019, guidance for 2020 and postpones publication of audited annual report for 2019 to March 11, 2020
6.14 Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors
6.15 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.16 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.17 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.18 Feb 18, 2020: Hologic Expands Costa Rican operations with new financial shared services center
6.19 Feb 05, 2020: Hologic launches new scalable options for panther system in the United States and Europe
6.20 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed
6.21 Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results
6.22 Jan 30, 2020: Peter Korte to head Siemens Strategy
6.23 Jan 15, 2020: Accellix announces the appointment of Nir Nimrodi as chairman and chief executive officer
6.24 Jan 14, 2020: ABCAM: Appointment of Chief Financial Officer
6.25 Jan 13, 2020: T2 Biosystems promotes Tony Pare to Chief Commercial Officer
6.26 Jan 12, 2020: Hologic announces preliminary financial results for first quarter of fiscal 2020
6.27 Jan 12, 2020: Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance
6.28 Jan 10, 2020: Abcam : Half year trading update
6.29 Jan 09, 2020: rHEALTH Technology granted US patent for small volume blood handling in point-of-care devices
6.30 Jan 09, 2020: T2 Biosystems announces preliminary fourth quarter 2019 financial results
6.31 Jan 09, 2020: T2 Biosystems appoints industry veteran John Sperzel as chief executive officer
6.32 Jan 09, 2020: Pomerantz law firm investigates claims on behalf of investors of Baxter
6.33 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control
6.34 Dec 31, 2019: Redbud Labs expands team in response to increased demand
6.35 Dec 11, 2019: SQI Diagnostics Reports Fourth Quarter and Fiscal 2019 Results and Management Changes
6.36 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses
6.37 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
6.38 Dec 02, 2019: Rosen, a highly ranked firm, announces filing of securities class action lawsuit against Baxter International
7 Appendix
7.1 Methodology

and more…

https://jumbonews.co.uk/